Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Hip Replacement Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0015-1812

    Hip Replacement Surgery Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0015-1812 alerts

    Get alerted when Policy PUM 250-0015-1812 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs medical necessity and coverage criteria for primary hip arthroplasty, hip resurfacing, hemiarthroplasty, and revision or replacement of prior hip arthroplasty or resurfacing procedures, subject to the member’s benefit plan.

    Policy Summary
    PayerWPS Health Insurance
    PolicyHip Replacement Surgery Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateOct 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionReview the member’s contract and endorsements for applicable exclusions, prior authorization requirements, benefit limits, and other benefit requirements before services are performed.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    9Primary hip arthroplasty indication categories
    8Revision arthroplasty conditions
    2 weeksMedication trial
    6/10Average pain threshold

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    65 years
    Metal-on-metal resurfacing age limit
    FDA-approvedDevice approval status

    Hip Arthroplasty Medical Necessity

    Degenerative joint disease

    Hip arthroplasty is medically necessary for degenerative joint disease when ALL of the following are met.

    Degenerative joint disease criteria

    • Medication trial: The individual has trialed analgesic or anti-inflammatory medication for at least 2 weeks, unless contraindicated.at least 2 weeks
    • Imaging: Moderate to severe arthritis is shown on imaging.moderate to severe arthritis
    • Pain or functional impairment evidence

      • Pain score: Average pain level is 6 or greater on a scale of 0 to 10.6 or greater/10
      • Functional disability: Intermittent or continuous pain causes functional disability that interferes with activities of daily living.interferes with ADLs
      • Oxford Hip score is 29 or less.29 or less
    • Examination findings

      • Pain with passive range of motion of the hip.
      • Decreased range of motion of the hip.
      • Antalgic gait.

    Other primary hip arthroplasty indications

    Hip arthroplasty is medically necessary for any one of the following indications.

    Primary hip arthroplasty indications

    • Acute fracture: Acute femoral neck or acetabular fracture.
    • Intertrochanteric or per-trochanteric fracture: Intertrochanteric or per-trochanteric hip fracture with at least one of the following: avascular necrosis of the femoral head on the same hip; unstable or significantly displaced fracture; comminuted fracture; inflammatory arthritis; poor bone quality; osteoarthritis of the same hip; internal fixation complication; or neglected fracture.at least 1 listed feature
    • Failed fracture repair or healing: Failed repair or failed healing of a previous hip fracture causing pain or functional disability that interferes with activities of daily living.interferes with ADLs

    Customized prostheses and patient-specific instruments

    FDA-approved hip arthroplasty using customized prostheses and/or patient-specific instruments is medically necessary only for either of the following indications.

    Permitted customized technology indications

    • Complex fracture: Complex periarticular hip or pelvis fracture.
    • Revision for periprosthetic fracture: Revision arthroplasty is required because of a periprosthetic fracture.

    Revision hip arthroplasty or resurfacing

    Revision of a previous hip arthroplasty or resurfacing procedure is medically necessary when the condition causes pain or functional disability that interferes with the ability to perform activities of daily living and any one of the following is present.

    Revision indications

    • Mechanical failure, fracture, or loosening of the prosthetic demonstrated on imaging.demonstrated on imaging
    • Nonunion of the previous hip replacement demonstrated on imaging.demonstrated on imaging
    • Recurrent dislocations: Recurrent hip dislocations demonstrated on imaging and nonresponsive to conservative management.imaging-confirmed; nonresponsive to conservative management

    Customized or personalized prostheses, patient-specific cutting instruments, and CT or MRI used to manufacture custom prostheses, create patient-specific instruments, or plan intraoperative navigation are medically necessary only for a complex periarticular hip or pelvis fracture or when revision arthroplasty is required because of a periprosthetic fracture. For all other indications, these technologies and related imaging are not medically necessary. Any device or prosthetic used must also be FDA-approved for the specific planned use.

    Hip replacement for a diagnosis listed in the indications of coverage is not medically necessary when the applicable criteria are not met. A condition or diagnosis not listed in the indications of coverage is considered experimental, investigational, and unproven to affect health outcomes.

    For a complex periarticular hip or pelvis fracture, customized or personalized prostheses, patient-specific instruments, and related CT or MRI may be medically necessary. The same exception applies when revision arthroplasty is required because of a periprosthetic fracture. For revision of a previous hip arthroplasty or resurfacing procedure for other causes, the condition must cause pain or functional disability interfering with activities of daily living, with supporting evidence such as imaging-confirmed mechanical failure, fracture, loosening, nonunion, recurrent dislocation unresponsive to conservative management, irreducible dislocation, periprosthetic infection confirmed by culture or gram stain, significant leg-length discrepancy affecting gait or function, or implant-related metallosis or hypersensitivity.

    For other indications, custom implants or prostheses, patient-specific instruments, and CT or MRI used for manufacture or intraoperative navigation planning are not medically necessary. A listed diagnosis that does not meet its applicable criteria is also not medically necessary; an unlisted diagnosis is considered experimental, investigational, and unproven.

    Clinical Thresholds and Coding Details

    Analgesic or anti-inflammatory medication trial
    Medication typeAnalgesic or anti-inflammatory medication
    Minimum trialAt least 2 weeks
    ExceptionUnless contraindicated
    Average pain level
    Average pain threshold6 or greater
    Pain scale0 to 10
    Coverage contextA documented option supporting degenerative joint disease coverage

    Authorization, Documentation, and Denial Risks

    Prior Authorization

    Verify Plan Authorization Requirements

    Review the member’s contract and endorsements before requesting or performing services. Confirm applicable exclusions, prior authorization requirements, benefit limits, and other plan-specific requirements; this guideline does not itself constitute plan authorization or a guarantee of payment.

    Documentation Required

    Standard Written Order Required

    Submit a standard written order prescribed by a qualified healthcare provider that concerns the member’s diagnosis.

    Documentation Required

    Clinical Records and Conservative Treatment

    Hip Arthroplasty Overview

    Hip replacement, also called hip arthroplasty, surgically replaces damaged bone and cartilage in the hip joint with a man-made implant. Depending on the procedure, the implant replaces the affected joint surfaces and restores the articulation between the pelvis and the proximal femur. The guideline addresses primary arthroplasty for degenerative, traumatic, inflammatory, congenital, malignant, and osteonecrotic conditions, as well as revision procedures for failed or complicated prior arthroplasty. Coverage generally depends on documented pain or functional impairment, appropriate imaging and clinical findings, and failure or inappropriateness of conservative or alternative treatment when required.

    Key Terms

    Hip replacement / hip arthroplasty
    TermHip replacement or hip arthroplasty
    Surgical definitionSurgical replacement of damaged bone and cartilage from the hip joint
    ImplantA man-made implant
    Neglected fracture
    TermNeglected fracture
    DefinitionA delay from the time of injury to seeking medical treatment
    Clinical contextA qualifying feature of an intertrochanteric or per-trochanteric hip fracture
    Policy Summary
    PayerWPS Health Insurance
    PolicyHip Replacement Surgery Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateOct 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionReview the member’s contract and endorsements for applicable exclusions, prior authorization requirements, benefit limits, and other benefit requirements before services are performed.
    SourceLink
    On This Page
    Hip Arthroplasty Medical NecessityClinical Thresholds and Coding DetailsAuthorization, Documentation, and Denial RisksHip Arthroplasty OverviewKey Terms
  1. Malignancy affecting the pelvic bones, proximal femur, or associated soft tissues.
  2. Chronic dislocation of the hip.
  3. Hemophilic or inflammatory arthropathy with advanced arthritic changes, decreased range of motion, pain or functional disability that interferes with activities of daily living, and other interventions such as synovectomy, arthrodesis, or osteotomy that are not appropriate or have failed.all listed findings
  4. Congenital deformity or dysplasia: Congenital deformity or hip dysplasia causing pain or functional disability that interferes with activities of daily living.interferes with ADLs
  5. Symptomatic osteonecrosis of the femoral head with collapse or imaging demonstrating arthritis at Ficat stage II or higher.Ficat stage II or higher
  6. Irreducible dislocation: Hip dislocation that is irreducible.
  7. Periprosthetic infection confirmed by culture or gram stain.culture or gram stain confirmed
  8. Periprosthetic fracture demonstrated on imaging.demonstrated on imaging
  9. Leg length discrepancy: Significant leg length discrepancy affecting gait or functional ability.significant and affects gait or function
  10. Metallosis or hypersensitivity reaction caused by the previous hip implant.caused by previous implant
  11. Oxford Hip score
    AssessmentOxford Hip score
    Qualifying threshold29 or less
    Coverage contextA documented option supporting degenerative joint disease coverage
    Osteonecrosis severity
    ConditionSymptomatic osteonecrosis of the femoral head
    Qualifying severityFicat stage II or higher
    Required evidenceFemoral-head collapse or imaging demonstrating arthritis
    Metal-on-metal resurfacing age
    ProcedureMetal-on-metal hip resurfacing
    Age thresholdGreater than 65 years
    Coverage statusExperimental, investigational, and unproven

    Submit medical records supporting the diagnosis and medical necessity, including history and physical findings, pain and physical or functional impairment, imaging studies, and conservative treatment trials such as medication or physical therapy. Include documentation of continued need or use when applicable.

    Documentation Required

    Postoperative Facility Extension Documentation

    For requested extensions of inpatient rehabilitation facility or skilled nursing facility stays, submit therapy evaluations and daily progress notes. For skilled nursing facility extensions based on nursing need, provide nursing assessments and progress notes as indicated by the applicable MCG review.

    Billing Rule

    Correct Coding Required

    Use correct coding for the item or service and comply with all applicable coding guidelines.

    Documentation Required

    FDA Approval Documentation

    Only devices and prosthetics approved by the U.S. FDA for the specific planned use may be used. The surgeon is responsible for verifying FDA approval and documenting that verification before the procedure.

    Denial Risk

    Unlisted Diagnosis or Unmet Criteria

    If the condition or diagnosis is not listed in the Indications of Coverage, the use is considered experimental, investigational, and unproven to affect health outcomes. If the diagnosis is listed but the applicable criteria are not met, the service is considered not medically necessary.

    • Unlisted indication or diagnosis: experimental, investigational, and unproven.
    • Listed indication without satisfied criteria: not medically necessary.
    Denial Risk

    Non-FDA-Approved Device

    Flag any device or prosthetic that has not been approved by the U.S. FDA for the specific planned use. Such use is considered experimental, investigational, and unproven to affect health outcomes and is not covered under the guideline.

    Denial Risk

    Unapproved Custom Technology Use

    Patient-specific instruments and custom implants or prostheses are not medically necessary except for the specified covered indications. CT or MRI used to manufacture custom prostheses or patient-specific instruments, or to plan intraoperative navigation, is medically necessary only for complex periarticular hip or pelvis fractures or revision arthroplasty required because of a periprosthetic fracture.

    • Includes custom systems such as the Conformis Hip System.
    • The exception applies only when the applicable indication and criteria are met.
    Denial Risk

    Experimental or Unproven Services

    Identify services considered experimental, investigational, and unproven to affect health outcomes before submission or performance. These services are not medically necessary under the guideline and will not be covered.

    • Metal-on-metal hip resurfacing for individuals older than 65 years.
    • Intraoperative surgical navigation, including intellijoint HIP® and OrthoGrid Hip AI, and robotic assistance for hip arthroplasty, including Mako SmartRobotics; these are considered integral to the surgical procedure.
    • Radlink Galileo Positioning System (GPS).
    • Home use of continuous passive motion (CPM) devices and related equipment or supplies.
    • iOVERA® System; Coolief® Cooled RF; viscosupplementation or hyaluronic acid injections; stem cell therapy or injections; platelet-rich plasma injections.
    • Peripheral nerve block of the articular branches of the femoral or obturator nerve unless provided intraoperatively; radiofrequency ablation of those articular branches.
    • Cryotherapy or cold therapy devices; bone marrow aspirate concentrate (BMAC); microfragmented adipose tissue (MFAT), including Lipogems®; platelet lysate (PL); and 3D-printed orthopedic implants.
    Symptomatic osteonecrosis
    ConditionAvascular necrosis of the femoral head
    Qualifying findingsFemoral-head collapse or imaging demonstrating arthritis
    Severity thresholdFicat stage II or higher